{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:36:31Z","timestamp":1791020191651,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"NEI","doi-asserted-by":"publisher","award":["K08EY027464"],"award-info":[{"award-number":["K08EY027464"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ophtha.2023.12.014","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T02:13:57Z","timestamp":1702347237000},"page":"622-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-9885","authenticated-orcid":false,"given":"Anthony B.","family":"Daniels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1193-6686","authenticated-orcid":false,"given":"Emmanuel Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-9802","authenticated-orcid":false,"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan S.","family":"Gombos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-7982","authenticated-orcid":false,"given":"Michael B.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3288-3632","authenticated-orcid":false,"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry E.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ophtha.2023.12.014_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"9374","key":"10.1016\/j.ophtha.2023.12.014_bib2","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ophtha.2023.12.014_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1159\/000369362","article-title":"Management of von Hippel-Lindau disease: an interdisciplinary review","volume":"37","author":"Schmid","year":"2014","journal-title":"Oncol Res Treat"},{"issue":"5112","key":"10.1016\/j.ophtha.2023.12.014_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"issue":"6733","key":"10.1016\/j.ophtha.2023.12.014_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ophtha.2023.12.014_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.ophtha.2023.12.014_bib60","doi-asserted-by":"crossref","first-page":"e92193","DOI":"10.1172\/jci.insight.92193","article-title":"Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch","volume":"3","author":"Arreola","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.ophtha.2023.12.014_bib7","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1097\/IAE.0000000000002572","article-title":"Management of retinal hemangioblastoma in von Hippel-Lindau disease","volume":"39","author":"Wiley","year":"2019","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ophtha.2023.12.014_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archopht.126.5.637","article-title":"Retinal vascular proliferation as an ocular manifestation of von Hippel-Lindau disease","volume":"126","author":"Wong","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2023.12.014_bib9","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.ophtha.2008.01.027","article-title":"Clinical course of retrobulbar hemangioblastomas in von Hippel-Lindau disease","volume":"115","author":"Meyerle","year":"2008","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2023.12.014_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","article-title":"Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene","volume":"12","author":"Stolle","year":"1998","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.ophtha.2023.12.014_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0300-2977(01)00165-6","article-title":"Clinical management of von Hippel-Lindau (VHL) disease","volume":"59","author":"Hes","year":"2001","journal-title":"Neth J Med"},{"issue":"12","key":"10.1016\/j.ophtha.2023.12.014_bib12","first-page":"B4763:1","article-title":"von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition","volume":"60","author":"Binderup","year":"2013","journal-title":"Dan Med J"},{"issue":"1","key":"10.1016\/j.ophtha.2023.12.014_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/ERC-13-0308","article-title":"Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations","volume":"21","author":"Kruizinga","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"10.1016\/j.ophtha.2023.12.014_bib14","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","article-title":"von Hippel-Lindau and hereditary pheochromocytoma\/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood","volume":"23","author":"Rednam","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.ophtha.2023.12.014_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ncpuro0179","article-title":"Management of von Hippel-Lindau-associated kidney cancer","volume":"2","author":"Grubb","year":"2005","journal-title":"Nat Clin Pract Urol"},{"issue":"1","key":"10.1016\/j.ophtha.2023.12.014_bib16","first-page":"295","article-title":"Contemporary treatment of metastatic renal cell carcinoma","volume":"10","author":"Stukalin","year":"2016","journal-title":"Oncol Rev"},{"issue":"1","key":"10.1016\/j.ophtha.2023.12.014_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/jmedgenet-2016-104058","article-title":"Survival and causes of death in patients with von Hippel-Lindau disease","volume":"54","author":"Binderup","year":"2017","journal-title":"J\u00a0Med Genet"},{"issue":"19","key":"10.1016\/j.ophtha.2023.12.014_bib59","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/cncr.34896","article-title":"Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance","volume":"129","author":"Daniels","year":"2023","journal-title":"Cancer"},{"issue":"7183","key":"10.1016\/j.ophtha.2023.12.014_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","article-title":"Clinical guidelines: developing guidelines","volume":"318","author":"Shekelle","year":"1999","journal-title":"BMJ"},{"issue":"Pt 6","key":"10.1016\/j.ophtha.2023.12.014_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/eye.1991.133","article-title":"Ophthalmological screening for von Hippel-Lindau disease","volume":"5","author":"Moore","year":"1991","journal-title":"Eye (Lond)"},{"issue":"283","key":"10.1016\/j.ophtha.2023.12.014_bib21","first-page":"1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher","year":"1990","journal-title":"Q\u00a0J Med"},{"issue":"9","key":"10.1016\/j.ophtha.2023.12.014_bib22","first-page":"3067","article-title":"Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study","volume":"43","author":"Dollfus","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2023.12.014_bib23","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.ophtha.2006.02.059","article-title":"Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study","volume":"113","author":"Kreusel","year":"2006","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2023.12.014_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ophtha.2007.03.009","article-title":"Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2023.12.014_bib25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/neuonc\/nov313","article-title":"von Hippel-Lindau disease: an evaluation of natural history and functional disability","volume":"18","author":"Feletti","year":"2016","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.ophtha.2023.12.014_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bjophthalmol-2017-310884","article-title":"Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease","volume":"102","author":"Binderup","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2023.12.014_bib27","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/ajmg.a.38324","article-title":"von Hippel-Lindau development in children and adolescents","volume":"173","author":"Launbjerg","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ophtha.2023.12.014_bib28","series-title":"von Hippel-Lindau Disease\u2014A Comprehensive Guide to Diagnosis, Treatment, and Management","article-title":"Retinal hemangioblastomas","author":"Milam","year":"2024"},{"key":"10.1016\/j.ophtha.2023.12.014_bib29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(64)90107-X","article-title":"Lindau\u2019s disease. Review of the literature and study of a large kindred","volume":"36","author":"Melmon","year":"1964","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.ophtha.2023.12.014_bib30","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00345-020-03441-3","article-title":"Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease","volume":"39","author":"Chahoud","year":"2021","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.ophtha.2023.12.014_bib31","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3171\/2021.3.JNS204203","article-title":"Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement","volume":"136","author":"Huntoon","year":"2021","journal-title":"J Neurosurg"},{"issue":"Suppl 2","key":"10.1016\/j.ophtha.2023.12.014_bib32","first-page":"e225","article-title":"Endolymphatic sac tumor screening and diagnosis in von Hippel-Lindau disease: a consensus statement","volume":"83","author":"Mehta","year":"2021","journal-title":"J Neurol Surg B Skull Base"},{"issue":"3","key":"10.1016\/j.ophtha.2023.12.014_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cncr.33978","article-title":"Management recommendations for pancreatic manifestations of von Hippel-Lindau disease","volume":"128","author":"Laks","year":"2022","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ophtha.2023.12.014_bib34","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0161-6420(01)00758-8","article-title":"Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2023.12.014_bib36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.0b013e3182661f3c","article-title":"Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease","volume":"79","author":"Frantzen","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ophtha.2023.12.014_bib37","first-page":"818","article-title":"Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease","volume":"117","author":"Ye","year":"2012","journal-title":"J\u00a0Neurosurg"},{"issue":"17","key":"10.1016\/j.ophtha.2023.12.014_bib38","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0000000000002064","article-title":"New von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy","volume":"85","author":"Binderup","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ophtha.2023.12.014_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9394(99)00199-3","article-title":"Postpartum cerebellar herniation in von Hippel-Lindau syndrome","volume":"128","author":"Othmane","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.014_bib41","unstructured":"AK-FLUOR (fluorescein sodium) injection for intravenous use [Package Insert]. HF Acquisition Co LLC, DBA HealthFirst. Revision Date: 8\/2019."},{"issue":"4","key":"10.1016\/j.ophtha.2023.12.014_bib42","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IAE.0000000000001601","article-title":"Early detection of retinal hemangioblastomas in von Hippel-Lindau disease using ultra-widefield fluorescein angiography","volume":"38","author":"Chen","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2023.12.014_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2350-11-4","article-title":"Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease","volume":"11","author":"Rasmussen","year":"2010","journal-title":"BMC Med Genet"},{"issue":"6","key":"10.1016\/j.ophtha.2023.12.014_bib44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/GIM.0b013e3182091a1d","article-title":"Compliance with periodic surveillance for von-Hippel-Lindau disease","volume":"13","author":"Lammens","year":"2011","journal-title":"Genet Med"},{"issue":"15","key":"10.1016\/j.ophtha.2023.12.014_bib61","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/cncr.34265","article-title":"Multidisciplinary integrated care pathway for von Hippel-Lindau disease","volume":"128","author":"Wolters","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2023.12.014_bib45","doi-asserted-by":"crossref","first-page":"c951","DOI":"10.1136\/bmj.c951","article-title":"Multidisciplinary team working in cancer: what is the evidence?","volume":"340","author":"Taylor","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ophtha.2023.12.014_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JOP.2014.003350","article-title":"Reviewing cancer care team effectiveness","volume":"11","author":"Taplin","year":"2015","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.ophtha.2023.12.014_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13023-015-0366-y","article-title":"High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease","volume":"10","author":"Van Groenendael","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ophtha.2023.12.014_bib48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/JMDH.S93680","article-title":"The role of the multidisciplinary health care team in the management of patients with Marfan syndrome","volume":"9","author":"von Kodolitsch","year":"2016","journal-title":"J\u00a0Multidiscip Healthc"},{"issue":"1","key":"10.1016\/j.ophtha.2023.12.014_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13023-019-1072-y","article-title":"A\u00a0step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report","volume":"14","author":"Auvin","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.ophtha.2023.12.014_bib50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ophtha.2010.04.031","article-title":"Vitreoretinal surgery for severe retinal capillary hemangiomas in von Hippel-Lindau disease","volume":"118","author":"Gaudric","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2023.12.014_bib51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/IAE.0000000000000707","article-title":"Pars plana vitrectomy in advanced cases of von Hippel-Lindau eye disease","volume":"36","author":"Krzystolik","year":"2016","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ophtha.2023.12.014_bib52","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0161-6420(98)98017-4","article-title":"Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma","volume":"105","author":"Kreusel","year":"1998","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2023.12.014_bib53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ophtha.2003.04.003","article-title":"Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease: visual and anatomic outcomes","volume":"111","author":"Raja","year":"2004","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ophtha.2023.12.014_bib54","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0161-6420(02)01177-6","article-title":"Treatment of retinal capillary hemangioma","volume":"109","author":"Singh","year":"2002","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2023.12.014_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.oret.2016.08.004","article-title":"Laser photocoagulation for peripheral retinal capillary hemangioblastoma in von Hippel-Lindau disease","volume":"1","author":"Krivosic","year":"2017","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"10.1016\/j.ophtha.2023.12.014_bib56","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1158\/2159-8290.CD-NB2021-0377","article-title":"FDA OK\u2019s HIF2\u03b1 inhibitor belzutifan","volume":"11","year":"2021","journal-title":"Cancer Discov"},{"issue":"22","key":"10.1016\/j.ophtha.2023.12.014_bib57","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ophtha.2023.12.014_bib58","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1097\/IAE.0000000000002555","article-title":"von Hippel-Lindau Disease: update on pathogenesis and systemic aspects","volume":"39","author":"Aronow","year":"2019","journal-title":"Retina"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023008953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023008953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T04:16:52Z","timestamp":1713413812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642023008953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0161642023008953"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.014","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}